Pages that link to "Q58459763"
Jump to navigation
Jump to search
The following pages link to Alastair Forbes (Q58459763):
Displaying 50 items.
- Independent and population-specific association of risk variants at the IRGM locus with Crohn's disease (Q22242868) (← links)
- A Nonsynonymous SNP in ATG16L1 Predisposes to Ileal Crohn’s Disease and Is Independent of CARD15 and IBD5 (Q22250941) (← links)
- Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls (Q24550675) (← links)
- IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease (Q24645890) (← links)
- Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants (Q24646663) (← links)
- Association of DLG5 R30Q variant with inflammatory bowel disease (Q28246016) (← links)
- Genetic variation in myosin IXB is associated with ulcerative colitis (Q28272638) (← links)
- Human atrial natriuretic factor and renin-aldosterone in paracetamol induced fulminant hepatic failure (Q28326416) (← links)
- Calcipotriol inhibits rectal epithelial cell proliferation in ulcerative proctocolitis (Q28368328) (← links)
- Hypermanganesemia in long-term intravenous nutrition and chronic liver disease (Q28376980) (← links)
- Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility (Q29614872) (← links)
- The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study. (Q33431815) (← links)
- Radiation-induced bowel injury: the impact of radiotherapy on survivorship after treatment for gynaecological cancers (Q33459118) (← links)
- Trial Protocol: Communicating DNA-based risk assessments for Crohn's disease: a randomised controlled trial assessing impact upon stopping smoking (Q33797350) (← links)
- Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease. (Q33904957) (← links)
- Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn's disease. (Q34367414) (← links)
- Association between Meckel's diverticulum and Crohn's disease: a retrospective review (Q34379267) (← links)
- Acupuncture for irritable bowel syndrome: a blinded placebo-controlled trial. (Q34431187) (← links)
- Resolution of salmonella carriage after duodenoscopic treatment for a common bile duct stone (Q34556263) (← links)
- Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework (Q35061087) (← links)
- Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease (Q35364265) (← links)
- Diagnostic and clinical significance of Crohn's disease-specific anti-MZGP2 pancreatic antibodies by a novel ELISA. (Q35523768) (← links)
- Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial. (Q35595821) (← links)
- Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. (Q35597079) (← links)
- Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. (Q35598279) (← links)
- Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease (Q35760252) (← links)
- Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. (Q35760415) (← links)
- Most dysplasia in ulcerative colitis is visible at colonoscopy. (Q35872709) (← links)
- Effect of communicating DNA based risk assessments for Crohn's disease on smoking cessation: randomised controlled trial (Q36106164) (← links)
- Ileal inflammation may trigger the development of GP2-specific pancreatic autoantibodies in patients with Crohn's disease. (Q36355419) (← links)
- Lipomatosis of the ileocaecal valve simulating Crohn's disease (Q36682668) (← links)
- Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte-colony stimulating factor. (Q37110990) (← links)
- Abnormal thymic stromal lymphopoietin expression in the duodenal mucosa of patients with coeliac disease (Q37282566) (← links)
- Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease (Q37284963) (← links)
- Nutritional supplement usage in patients admitted to a spinal cord injury center (Q37317767) (← links)
- Medical management of patients with ileal pouch anal anastomosis after restorative procto-colectomy (Q37326378) (← links)
- Estimating risks of common complex diseases across genetic and environmental factors: the example of Crohn disease. (Q37363244) (← links)
- A novel prion disease associated with diarrhea and autonomic neuropathy (Q37393739) (← links)
- Perianal fistulae in Crohn's Disease: current and future approaches to treatment. (Q37616110) (← links)
- ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. (Q38259742) (← links)
- Management of acute intestinal failure: A position paper from the European Society for Clinical Nutrition and Metabolism (ESPEN) Special Interest Group (Q38874179) (← links)
- FOXE1 and SYNE1 genes hypermethylation panel as promising biomarker in colitis-associated colorectal neoplasia. (Q39306701) (← links)
- Plasma citrulline as a quantitative biomarker of HIV-associated villous atrophy in a tropical enteropathy population. (Q39337332) (← links)
- Tumour recurrence is associated with Jass grouping but not with differences in E-cadherin expression in moderately differentiated Dukes' B colorectal cancers. (Q39563871) (← links)
- Profile and prevalence of malnutrition in children with spinal cord injuries—assessment of the Screening Tool for Assessment of Malnutrition in Paediatrics (STAMP) (Q39686995) (← links)
- Anti-tumor necrosis factor-alpha-loaded microspheres as a prospective novel treatment for Crohn's disease fistulae (Q39779660) (← links)
- An analysis of predictive factors for healing and mortality in patients with enterocutaneous fistulas. (Q40064160) (← links)
- Functional symptoms in inflammatory bowel disease and their potential influence in misclassification of clinical status. (Q40450087) (← links)
- Release of angiogenic growth factors from cells encapsulated in alginate beads with bioactive glass. (Q40467644) (← links)
- Defining malnutrition: A plea to rethink (Q40492613) (← links)